Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation

Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment

(2019) Jordan Guillon et al.   Cell Death & Disease

Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence

(2018) Guillaume Collin et al.   Cell Death & Disease

Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies

(2017) Paul Lesueur et al.   Oncotarget

Context-dependent effects of cellular senescence in cancer development

(2016) Pacome Lecot et al.   BRITISH JOURNAL OF CANCER

Optimize and refine therapeutic index in radiation therapy: Overview of a century

(2016) Cyrus Chargari et al.   CANCER TREATMENT REVIEWS

Senescence: Adaptation to DNA repair targeting drugs?

(2016) Olivier Coqueret   CELL CYCLE

Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?

(2016) Brian Budke et al.   ChemMedChem

Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells

(2016) Moureq Alotaibi et al.   RADIATION RESEARCH

Tumor Cell Recovery from Senescence Induced by Radiation with PARP Inhibition

(2016) David A. Gewirtz et al.   RADIATION RESEARCH

Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51

(2015) Ambber Ward et al.   CANCER TREATMENT REVIEWS

Combining carbon ion irradiation and non-homologous end-joining repair inhibitor NU7026 efficiently kills cancer cells

(2015) Hongyu Ma et al.   Radiation Oncology

Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1

(2015) Barbara Jonchère et al.   Oncotarget

Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells

(2015) Kathleen A. Bridges et al.   Oncotarget

A Small Molecule Inhibitor of Human RAD51 Potentiates Breast Cancer Cell Killing by Therapeutic Agents in Mouse Xenografts

(2014) Fei Huang et al.   PLoS One

A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin

(2014) David A. Alagpulinsa et al.   Frontiers in Oncology

Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer

(2013) Judith Michels et al.   CELL CYCLE

Mechanisms of resistance to therapies targeting BRCA-mutant cancers

(2013) Christopher J Lord et al.   NATURE MEDICINE

Charged particle therapy—optimization, challenges and future directions

(2013) Jay S. Loeffler et al.   Nature Reviews Clinical Oncology

Low-LET Proton Irradiation of A549 Non-small Cell Lung Adenocarcinoma Cells: Dose Response and RBE Determination

(2013) Anne-Catherine Wéra et al.   RADIATION RESEARCH

Comparison of X-ray and alpha particle effects on a human cancer and endothelial cells: Survival curves and gene expression profiles

(2013) Hélène Riquier et al.   RADIOTHERAPY AND ONCOLOGY

A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2

(2012) Katharina Schlacher et al.   CANCER CELL

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells

(2012) H. Cheng et al.   CARCINOGENESIS

Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 Recombinase

(2012) Fei Huang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor

(2012) Louise J Barber et al.   JOURNAL OF PATHOLOGY

Past, present and future of radiotherapy for the benefit of patients

(2012) Juliette Thariat et al.   Nature Reviews Clinical Oncology

The combination of olaparib and camptothecin for effective radiosensitization

(2012) Katsutoshi Miura et al.   Radiation Oncology

Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer

(2012) Ashish Juvekar et al.   Cancer Discovery

Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening

(2011) Fei Huang et al.   ACS Chemical Biology

Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft

(2011) J. M. Senra et al.   MOLECULAR CANCER THERAPEUTICS

In vitro irradiation station for broad beam radiobiological experiments

(2011) A.-C. Wéra et al.   NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS

Therapy-Induced Senescence in Cancer

(2010) Jonathan A. Ewald et al.   JNCI-Journal of the National Cancer Institute

Radiation-induced cell death mechanisms

(2010) David Eriksson et al.   TUMOR BIOLOGY

Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo

(2009) Florence Debacq-Chainiaux et al.   Nature Protocols

Charged particles in radiation oncology

(2009) Marco Durante et al.   Nature Reviews Clinical Oncology

Replication-Dependent Radiosensitization of Human Glioma Cells by Inhibition of Poly(ADP-Ribose) Polymerase: Mechanisms and Therapeutic Potential

(2008) Fiona A. Dungey et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS